Welcome to the e-CCO Library Archive!

Filter:
P238. Granulocytapheresis on the treatment of ulcerative colitis: Results from four centres in Castile and Leon
P238. Serum CRP level and loss of infliximab response in early phase can be markers for abdominal abscess for Crohn's disease; a report by multivariate study
P238

Accuracy of fecal calprotectin predicting endoscopic activity in Inflammatory Bowel Disease patients

Authors:

V. Jusué, M. Chaparro, J.P. Gisbert*

Hospital Universitario de La Princesa, IIS-IP and CIBERehd, Gastroenterology Unit, Madrid, Spain

P239.

Diagnostic delay in pediatric Crohn's disease patients is longer than in pediatric ulcerative colitis patients

Authors:

A. Schoepfer1, E. Safroneeva2, N. Fournier3,4, G. Rogler5, A. Nydegger6, S. Vavricka5, C. Braegger7, 1Centre Hospitalier Universitaire Vaudois, Gastroenterology, Lausanne, Switzerland, 2University of Bern, Institute of Social and Preventive Medicine, Bern, Switzerland, 3Institute of Social and Preventive Medicine, Healthcare Evaluation Unit, Lausanne, Switzerland, 4University of Lausanne, IUMSP, Lausanne, Switzerland, 5University of Zurich, Gastroenterology and Hepatology, Zurich, Switzerland, 6University of Lausanne, Pediatric Gastroenterology, Lausanne, Switzerland, 7University of Zurich, Pediatric Gastroenterology, Zurich, Switzerland

P239. Faecal lactoferrin and calprotectin level in fistulizing and non fistulizing Crohn's disease
Authors:

M. Manelska1, L. Paradowski1, 1Medical University in Wroclaw Poland, Clinic of Gastroenterology and Hepatology, Wroclaw, Poland

P239. Methotrexate as a third-line therapy after thiopurine and anti‑TNF failure in Crohn's disease
P239. Mycophenolate mofetil in inflammatory bowel disease: The experience of a third level hospital
P239

Evolution of the lemann index during the course of Crohn's disease (CD)

Authors:

C. Gilletta*1, M. Lewin2, A. Bourrier3, I. Nion-Larmurier3, S. Rajca3, L. Beaugerie3, H. Sokol3, B. Pariente4, P. Seksik3, J. Cosnes3

1CHU de Caen, Department of Gastroenterology, Caen, France, 2APHP Saint-Antoine, Department of Radiology, Paris, France, 3Hopital Saint Antoine, Department of Gastroenterology, Paris, France, 4CHU de Lille, Department of Gastroenterology, Lille, France

P240.

Diagnosis of iron deficiency in inflammatory bowel diseases by transferrin receptor-ferritin index

Authors:

V. Abitbol1, A. Esch1, D. Borderie2, V. Polin1, T. Tabouret1, M. Dhooge1, G. Perkins1, F. Maksimovic1, S. Chaussade1, 1Hôpital Cochin, Gastroenterology, Paris, France, 2Hôpital Cochin, Biochemistry Laboratory, Paris, France

P240. A study of infliximab therapy for Crohn's disease following NICE TAG 187 in two UK district general hospitals
P240. Faecal lactoferrin and calprotectin level in evaluation of disease phenotype in Crohn's disease
Authors:

M. Manelska1, L. Paradowski1, 1Medical University in Wroclaw Poland, Clinic of Gastroenterology and Hepatology, Wroclaw, Poland

P240. Predicting response to thiopurines – A single centre experience
P240

Correlation between the Ulcerative Colitis Endoscopic Index of severity (UCEIS) and intestinal mucosal calprotectin (IMC) in acute severe ulcerative colitis.

Authors:

J. Chamoun*, L. Wang, C. Corte, L. Clifton, E. Wendt, M. Guirgis, S. Travis, S. Keshav

John Radcliffe Hospital, Translational Gastroenterology Unit, Oxford, United Kingdom

P241.

Development of a novel prediction model for natural course in Crohn's disease: A Korean multicenter, retrospective cohort study

Authors:

Y. Park1, J.H. Cheon2, W.H. Kim2, B.D. Ye3, Y.S. Kim4, D.S. Han5, J.S. Kim6, Y.H. Kim7, 1Yonsei University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 2Yonsei University College of Medicine, Department of Internal Medicine and Institute of Gastroenterology, Seoul, South Korea, 3University of Ulsan College of Medicine, Asan Medical Center, Gastroenterology, Seoul, South Korea, 4Inje University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 5Hanyang University Guri Hospital, Gastroenterology, Guri, Korea, Republic of, 6Seoul National University College of Medicine, Internal Medicine, Seoul, Korea, Republic of, 7Sungkyunkwan University School of Medicine, Internal Medicine, Seoul, Korea, Republic of

P241. Faecal calprotectin reliably predicts whether surveillance can be performed in patients with long-standing ulcerative or Crohn's colitis
Authors:

E. Mooiweer1, H.H. Fidder1, K.J. van Erpecum1, P.D. Siersema1, R.J. Laheij1, B. Oldenburg1, 1University Medical Centre Utrecht, Department of Gastroenterology and Hepatology, Utrecht, Netherlands

P241. Long-term (5 years) efficacy and safety of infliximab in Crohn's disease patients
P241. Thiopurines in the treatment of inflammatory bowel diseases (IBD) – A single centre experience
P241

Limitations in using fecal Calprotectin as a biomarker of IBD disease activity during Pregnancy

Authors:

A. Shitrit*1, S. Granovsky- Grisaru2, T. Adar3, B. Koslowsky3, D.M. Livovsky1, 3, S. Shteingart3, E. Goldin3

1Shaare Zedek Medical Center, Digestive Diseases Institute, Jerusalem, Israel, 2Shaare Zedek Medical Center, Department of obstetrics and gynecology, division of maternal fetal medicine, Jerusalem, Israel, 3Shaare Zedek Medical Center, Digestive diseases institute, Jerusalem, Israel

P242.

Development and psychometric testing of an inflammatory bowel disease fatigue (IBD-F) patient self-assessment scale

Authors:

W. Czuber-Dochan1, C. Norton1, P. Bassett2, S. Berliner3, F. Bredin4, M. Darvell5, A. Forbes6, M. Gay7, I. Nathan8, E. Ream1, H. Terry5, 1King's College London, Florence Nightingale School of Nursing & Midwifery, London, United Kingdom, 2Statsconsultancy, Medical Statistician, Amersham, United Kingdom, 3Crohn's and Colitis UK Trustee, Fatigue Steering Group, St Albans, United Kingdom, 4The Queen Elizabeth Hospital NHS Trust & Addenbrookes Hospital, Gastroenterology, King's Lynn & Cambridge, United Kingdom, 5Crohn's & Colitis UK Charity, CCUK, St Albans, United Kingdom, 6University College London, Gastroenterology, London, United Kingdom, 7Crohn's and Colitis UK, Fatigue Steering Group, St Albans, United Kingdom, 8University College London, Centre for Gastroenterology and Nutrition, London, United Kingdom

P242. Complementary and alternative medicine in inflammatory bowel disease patients. Is it a real problem?